Cardiff Oncology is a clinical-stage biotechnology company driving the development of novel cancer therapies through Polo-like Kinase 1 (PLK1) inhibition. The company heavily invests in rigorous clinical trials and scientific data analysis to advance its lead asset, onvansertib, across various cancer indications. This approach demands sophisticated systems for managing complex data sets and ensuring regulatory compliance.
This focus on advanced clinical development creates critical dependencies on robust data management, integration, and regulatory submission systems. Breakdown in these operational areas risks delays in trial progress, potential compliance issues, and slowed data-driven decision-making. This page analyzes Cardiff Oncology's digital transformation initiatives, the operational challenges they face, and where sellers can engage effectively.
Cardiff Oncology Snapshot
Headquarters: San Diego, CA, United States
Number of employees: 11-50 employees
Public or private: Public
Business model: B2B
Website: http://www.cardiffoncology.com
Cardiff Oncology ICP and Buying Roles
Cardiff Oncology sells to clinical research organizations, academic institutions, and pharmaceutical partners who collaborate on trial execution or drug development. They seek complex, specialized service providers for precision oncology development.
Who drives buying decisions
- Chief Medical Officer → Oversees clinical trial strategy and operational execution.
- Head of Clinical Operations → Manages ongoing clinical studies and data integrity.
- Head of Regulatory Affairs → Directs submissions to health authorities and ensures compliance.
- Head of Research and Development → Guides scientific inquiry and biomarker integration.
Key Digital Transformation Initiatives at Cardiff Oncology (At a Glance)
- Implementing advanced Clinical Data Management Systems for global trial data collection.
- Developing robust Regulatory Information Management systems for FDA submissions.
- Integrating Genomic and Biomarker data into patient response assessment workflows.
- Establishing Scientific Data Management platforms for preclinical research analytics.
Where Cardiff Oncology’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Trial Data Management | Implementing advanced Clinical Data Management Systems: inconsistent patient data appears across trial sites. | Head of Clinical Operations, Head of Data Management | Standardize data capture forms and validate entry at the source. |
| Implementing advanced Clinical Data Management Systems: manual checks are required for data reconciliation. | Head of Clinical Operations, Head of Data Management | Automate data validation rules before system ingestion. | |
| Implementing advanced Clinical Data Management Systems: integration of external lab data requires custom scripting. | Head of Clinical Operations, VP of Information Technology | Ingest external laboratory data directly without manual conversion. | |
| Regulatory Information Management | Developing robust Regulatory Information Management systems: submission documents contain outdated content versions. | Head of Regulatory Affairs, Senior Director of Quality Assurance | Control document versions before inclusion in regulatory packages. |
| Developing robust Regulatory Information Management systems: tracking regulatory commitments is a manual process. | Head of Regulatory Affairs, Chief Compliance Officer | Automate monitoring of submission deadlines and agency responses. | |
| Developing robust Regulatory Information Management systems: audit trails for submission content are incomplete. | Head of Regulatory Affairs, Senior Director of Quality Assurance | Enforce comprehensive logging of all changes to regulatory documents. | |
| Precision Medicine Data Integration | Integrating Genomic and Biomarker data: manual correlation of genomic data with clinical outcomes is slow. | Head of Research and Development, Chief Medical Officer | Link genomic sequences to individual patient clinical profiles. |
| Integrating Genomic and Biomarker data: biomarker data does not align with patient clinical records. | Head of Research and Development, Head of Clinical Operations | Harmonize biomarker data identifiers with clinical trial subject IDs. | |
| Integrating Genomic and Biomarker data: data pipelines for omics data processing fail to complete. | VP of Information Technology, Data Engineering Lead | Monitor data pipeline health for processing large genomic files. | |
| Scientific Data Management | Establishing Scientific Data Management platforms: research data is siloed across multiple laboratory systems. | Head of Research and Development, Laboratory Director | Centralize research data from diverse instruments and experiments. |
| Establishing Scientific Data Management platforms: retrieval of specific preclinical study results is difficult. | Head of Research and Development, Research Scientist | Index research data for rapid search and retrieval of study parameters. | |
| Establishing Scientific Data Management platforms: sharing research data with external partners is not secure. | VP of Information Technology, Head of Research and Development | Enforce secure access controls for sharing intellectual property. |
Identify when companies like Cardiff Oncology are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Cardiff Oncology’s digital transformation unique
Cardiff Oncology’s digital transformation centers on the precise management of complex clinical and scientific data crucial for drug development and regulatory approval. They depend heavily on integrating diverse data streams like genomics, biomarkers, and clinical trial results to refine treatment assessments. This necessitates systems that support advanced data correlation, a need distinct from companies focused on broader IT modernization. Their transformation is unique due to the stringent regulatory demands and the critical impact of data integrity on patient outcomes and FDA submissions.
Cardiff Oncology’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Trial Data Management
What the company is doing
Cardiff Oncology implements advanced Clinical Data Management Systems to collect, organize, and validate vast amounts of patient data from their ongoing Phase 2 trials. This includes data from multiple clinical sites, various patient assessments, and different treatment arms. The goal is to build a robust data foundation for future registrational studies.
Who owns this
- Head of Clinical Operations
- Head of Data Management
- Biostatisticians
Where It Fails
- Case Report Form (CRF) data contains incomplete entries before database lock.
- External laboratory results require manual upload into the Electronic Data Capture (EDC) system.
- Data queries from clinical sites remain unresolved past critical deadlines.
- Integration between the EDC system and statistical analysis software requires manual export and import steps.
Talk track
Looks like Cardiff Oncology manages extensive clinical trial data for ongoing studies. Been looking at how some clinical-stage biotechs validate data at the source instead of fixing errors later, happy to share what we’re seeing.
DT Initiative 2: Regulatory Submission Systems
What the company is doing
Cardiff Oncology develops robust Regulatory Information Management (RIM) systems to prepare and submit comprehensive regulatory filings to the FDA and other health authorities. This includes managing a high volume of documents, ensuring compliance with submission guidelines, and tracking interactions with regulatory bodies. The company prepares for registrational development, requiring precise control over submission processes.
Who owns this
- Head of Regulatory Affairs
- Chief Compliance Officer
- Senior Director of Quality Assurance
Where It Fails
- Regulatory documents do not follow standardized naming conventions before assembly.
- Submission packages contain outdated versions of study reports or safety data.
- Tracking regulatory agency correspondence is scattered across email and shared drives.
- Audit trails for changes made to submission-ready documents are incomplete.
Talk track
Noticed Cardiff Oncology builds regulatory submission systems for its drug candidates. Been looking at how some biopharma companies control document versions rigorously before submission instead of facing rejections, can share what’s working if useful.
DT Initiative 3: Precision Medicine Data Integration
What the company is doing
Cardiff Oncology integrates genomic and biomarker data with clinical trial outcomes to refine patient response assessment and support precision medicine strategies. This involves combining complex molecular data with traditional clinical data to identify actionable insights for targeted therapies. They leverage this integration to understand treatment efficacy in specific patient populations.
Who owns this
- Head of Research and Development
- Chief Medical Officer
- Bioinformatics Lead
Where It Fails
- Genomic sequencing data does not link directly to individual patient clinical records.
- Biomarker assay results from different labs show inconsistent formats.
- Identifying patient subgroups based on combined genomic and clinical markers is a manual analytical process.
- Data pipelines for integrating omics data into clinical data warehouses fail without warning.
Talk track
Saw Cardiff Oncology integrates genomic and biomarker data for precision medicine. Been looking at how some oncology firms standardize biomarker data formats upfront instead of struggling with reconciliation later, happy to share what we’re seeing.
DT Initiative 4: Scientific Data Management
What the company is doing
Cardiff Oncology establishes scientific data management platforms to centralize and analyze preclinical research data. This includes data from various laboratory experiments, in vitro studies, and animal models to inform the development pipeline. They aim to ensure data integrity and accessibility for scientific discovery and validation.
Who owns this
- Head of Research and Development
- Laboratory Director
- Research Scientists
Where It Fails
- Preclinical research data is stored in disparate laboratory instrument software.
- Retrieving specific experimental protocols and associated results is a time-consuming manual search.
- Data from in vitro studies cannot be easily compared with in vivo model outcomes.
- Sharing large scientific datasets with external research collaborators is cumbersome.
Talk track
Seems like Cardiff Oncology manages extensive scientific data for preclinical research. Been looking at how some research teams centralize diverse lab data instead of searching siloed systems, can share what’s working if useful.
Who Should Target Cardiff Oncology Right Now
This account is relevant for:
- Clinical Data Management System providers
- Regulatory Information Management System vendors
- Bioinformatics and Genomic Data Integration platforms
- Scientific Data Management and Lab Informatics solutions
- Clinical Trial Analytics and Business Intelligence tools
Not a fit for:
- Basic CRM software without scientific data capabilities
- General enterprise resource planning systems
- Marketing automation platforms
- E-commerce fulfillment solutions
When Cardiff Oncology Is Worth Prioritizing
Prioritize if:
- You sell tools that validate clinical trial data at the point of entry and automate reconciliation.
- You sell systems that enforce version control and standardize content for regulatory submissions.
- You sell platforms that seamlessly integrate genomic, biomarker, and clinical data for patient stratification.
- You sell solutions that centralize disparate scientific data and enable rapid retrieval for research.
- You sell analytics platforms that provide real-time metrics on clinical trial progress and data quality.
Deprioritize if:
- Your solution does not address specific breakdowns in clinical, regulatory, or scientific data workflows.
- Your product is limited to generic IT infrastructure management without specialized biotech capabilities.
- Your offering requires extensive manual configuration for scientific data types or regulatory standards.
Who Can Sell to Cardiff Oncology Right Now
Clinical Data Management System Providers
Medidata Solutions - This company provides cloud-based solutions for clinical research, including electronic data capture (EDC), clinical data management, and trial analytics.
Why they are relevant: Inconsistent patient data appears across Cardiff Oncology's trial sites, requiring manual reconciliation before analysis. Medidata's EDC system can standardize data capture forms and apply real-time validation rules, preventing errors at the source and accelerating data lock.
Veeva Systems - This company offers cloud software for the life sciences industry, including clinical operations, data management, and quality control.
Why they are relevant: Cardiff Oncology experiences challenges with manual upload of external laboratory results into their clinical systems. Veeva Clinical Data Management can provide automated data ingestion pathways, directly integrating external lab data formats without custom scripting or manual intervention.
Regulatory Information Management System Vendors
IQVIA Technologies - This company provides a comprehensive suite of technology solutions for life sciences, including regulatory information management and document management.
Why they are relevant: Cardiff Oncology's submission packages sometimes contain outdated versions of study reports or safety data, risking regulatory delays. IQVIA's RIM system can enforce strict version control and provide a centralized, auditable repository for all regulatory content, ensuring submission accuracy.
Sparta Systems (Honeywell) - This company offers quality management software, including solutions for regulatory compliance and document control within regulated industries.
Why they are relevant: Tracking regulatory agency correspondence and commitments at Cardiff Oncology is a manual, fragmented process. Sparta Systems' quality and regulatory solutions can centralize communication tracking and automate alerts for deadlines, improving oversight and reducing compliance risks.
Bioinformatics and Genomic Data Integration Platforms
DNAnexus - This company provides a cloud-based platform for genomic and multi-omic data analysis and collaboration, designed for precision medicine research.
Why they are relevant: Cardiff Oncology struggles with manual correlation of genomic data with clinical outcomes, slowing patient stratification. DNAnexus can link genomic sequencing data directly to patient clinical records and enable integrated analysis, accelerating the identification of relevant biomarkers.
Seven Bridges Genomics - This company offers a bioinformatics ecosystem for large-scale genomic data analysis, management, and collaboration.
Why they are relevant: Biomarker assay results from different labs used by Cardiff Oncology often have inconsistent formats, complicating aggregation. Seven Bridges can provide standardized data ingestion pipelines and harmonization tools for various biomarker data types, ensuring data consistency for integrated analysis.
Scientific Data Management and Lab Informatics Solutions
Thermo Fisher Scientific (SampleManager LIMS) - This company provides laboratory information management systems (LIMS) that manage lab operations and scientific data.
Why they are relevant: Preclinical research data at Cardiff Oncology is often stored in disparate laboratory instrument software. SampleManager LIMS can centralize data from various lab instruments and experiments, providing a single, accessible repository for all scientific research data.
Dotmatics (Insight) - This company offers a research and development software platform that integrates scientific data, workflows, and analytics across the discovery pipeline.
Why they are relevant: Retrieving specific experimental protocols and associated results for Cardiff Oncology's preclinical studies is a time-consuming manual search. Dotmatics Insight can index and organize research data, allowing for rapid, searchable access to experimental details and outcomes, improving research efficiency.
Final Take
Cardiff Oncology scales its clinical development pipeline, particularly in late-stage trials for onvansertib. Breakdowns are visible in manual data reconciliation, inconsistent regulatory submissions, and siloed scientific data integration. This account is a strong fit if your solution directly addresses these operational failures in clinical data management, regulatory compliance, or precision medicine data workflows.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.